629 related articles for article (PubMed ID: 35455991)
1. Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.
Twarda-Clapa A; Olczak A; Białkowska AM; Koziołkiewicz M
Cells; 2022 Apr; 11(8):. PubMed ID: 35455991
[TBL] [Abstract][Full Text] [Related]
2. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
3. Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments.
Wasim R; Mahmood T; Siddiqui MH; Ahsan F; Shamim A; Singh A; Shariq M; Parveen S
Life Sci; 2022 Oct; 307():120860. PubMed ID: 35940220
[TBL] [Abstract][Full Text] [Related]
4. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
5. Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products.
Sahi AK; Verma P; Varshney N; Gundu S; Mahto SK
Appl Biochem Biotechnol; 2022 Jun; 194(6):2831-2855. PubMed ID: 35257316
[TBL] [Abstract][Full Text] [Related]
6. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor.
Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S
Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591
[TBL] [Abstract][Full Text] [Related]
7. Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.
Koerich S; Parreira GM; de Almeida DL; Vieira RP; de Oliveira ACP
Curr Neuropharmacol; 2023; 21(2):219-234. PubMed ID: 36154605
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
9. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
[TBL] [Abstract][Full Text] [Related]
10. Advanced Glycation End Products, Diabetes, and Bone Strength.
Yamamoto M; Sugimoto T
Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of advance glycation end products formation, gastrointestinal digestion, absorption and toxicity: A comprehensive review.
Feng N; Feng Y; Tan J; Zhou C; Xu J; Chen Y; Xiao J; He Y; Wang C; Zhou M; Wu Q
Int J Biol Macromol; 2023 Sep; 249():125814. PubMed ID: 37451379
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis.
Sellegounder D; Zafari P; Rajabinejad M; Taghadosi M; Kapahi P
Int Immunopharmacol; 2021 Sep; 98():107806. PubMed ID: 34352471
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Pertynska-Marczewska M; Merhi Z
Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
[TBL] [Abstract][Full Text] [Related]
16. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
17. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.
Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T
Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646
[TBL] [Abstract][Full Text] [Related]
18. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products (AGEs) and their involvement in liver disease.
Hyogo H; Yamagishi S
Curr Pharm Des; 2008; 14(10):969-72. PubMed ID: 18473847
[TBL] [Abstract][Full Text] [Related]
20. Male infertility: A proximate look at the advanced glycation end products.
Omolaoye TS; du Plessis SS
Reprod Toxicol; 2020 Apr; 93():169-177. PubMed ID: 32050094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]